Ocuphire Pharma
history and ref inhibition mechanism | Ocuphire Pharma
Company
Deck Type
Deck date
January 2023
Slide
6 of 31
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
history and ref inhibition mechanism | Ocuphire Pharma
Investor Presentation
May 2023
ref inhibition decreases abnormal angiogenesis | Ocuphire Pharma
Results
October 2022
novel and dual acting in an oral pill ref ref | Ocuphire Pharma
Investor Day
January 2022
history and ref inhibition mechanism | Ocuphire Pharma
Related slides by other companies
AstraZeneca
Results
November 2024
inflammation modulator cardiorenal disease | AstraZeneca
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase trial design meters | 9 Meters Biopharma
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights